An international workshop on cannabis product quality will be hosted on December 7th and 8th by ASTM and USP. Bedrocan will share her knowledge in this free online workshop. During these two days, standards and guidelines from USP, PhEur, ASTM and other relevant organizations will be discussed to help address the challenges related to cannabis quality. Science-based resources from these standards development organisations will be discussed to explore opportunities to harmonise the varying national requirements for cannabis quality for products intended for medical use and scientific research.
Currently, around the globe, there is inconsistency in the development and adoption of analytical methods for cannabis materials and products intended for medical use. The globalisation of production and trade means industry must meet varying standards to enter markets. Harmonisation across the Americas and Europe is the first step toward reducing technical barriers to trade and improving the quality of cannabis intended for medical and scientific use around the globe.
Addressing common challenges through harmonisation and alignment of quality standards across jurisdictions would serve to protect patients and promote research and improve public health across the globe. The start of the harmonisation process has already begun with Bedrocan meeting both the Dutch and German monograph, which soon will be superseded by the European monograph.
The international workshop on cannabis product quality will be held on the 7th and 8th of December from 8.00 am – 12.15 pm ET (2:00pm – 6:15pm CET). There is no fee to attend this event, registration is required and now open.
The objectives and scope of this workshop include:
- Obtain awareness of the existing data, regulatory framework and public policy for cannabis quality, public quality standards, and policy guidance documents on defining cannabis product quality attributes globally – initially from an American and European perspective.
- Understand the scientific basis for standards to explore potential harmonization among standards groups.
- Facilitate discussions between stakeholders to identify needs and challenges related to cannabis quality.
- Identify areas of global data gaps to inform future standards and research needs.
The workshop will also include four panel sessions across both days. Bedrocan founder, Tjalling Erkelens, will be one of the panelist in the industry panel on day two, the 8th of December. Tjalling will share information on the industry experiences in meeting regulatory requirements and in utilizing the available standards for medical cannabis quality.
About the ASTM
ASTM International is a leading international standards development organization with over 12,800 standards operating globally. ASTM formed Committee D37 on Cannabis in 2017 to develop and maintain standards and guidance materials for cannabis products and processes.
USP is an independent, scientific organization focused on building trust in the supply of safe, quality medicines by setting public quality standards and publishing a pharmacopeia. USP formed an Expert Panel of Medical Cannabis in 2016 to develop quality standards for cannabis used for medical purposes.